| All volunteers in PhaseOneTrials are healthy subjects, and they are examined
for the highest level of health and safety standards. The safety of our
volunteers is our responsibility, and we never make compromises about this
responsibility. |
| |
| Quality control |
We inform volunteers for clinical phase I trials how the study will be
conducted both verbally and in writing. Only after receiving this information
do participants consent – voluntarily – to take part in a study.
Before we conduct a study with volunteer participants, the study is approved
by the Regional Independent Ethics Committee and the Danish Medicines Agency.
These organizations evaluate if it is ethically and scientifically responsible
to test the drug candidate in humans. |
| |
| If you would like to become a volunteer, click
here |
| |
| In phase II trials, a drug is tested on small groups of patients who have
the disease which the drug targets. Also here, the safety of the patients
is naturally our primary concern – and responsibility. |
| |
| Through its own databases or via cooperation with specialist hospital
wards, PhaseOneTrials also has access to a variety of patient populations,
including patients with: |
| |
- Psoriasis
- Osteoporosis or osteopenia
- Diabetes
- Reduced liver function
- Reduced kidney function
- Chronic hepatitis C
|
|  |
 |
